Arthritis Clinical Trial
Official title:
Prospective Evaluation of Vitagel for Reduction in Blood Loss and Pain Following Unilateral Total Knee Arthroplasty
Vitagel® is an FDA approved class III medical device. It is a surgical hemostat, which has
been shown to control bleeding during orthopaedic, cardiac, hepatic, and general surgical
procedures. The product is a thrombin/collagen suspension which works in combination with
the patient's own plasma to form a fibrin/collagen clot.
The present prospective, randomized controlled trial is designed to evaluate the efficacy of
Vitagel® for reducing blood loss and pain in patients managed with unilateral total knee
arthroplasty (TKA). It is hypothesized that the use of Vitagel® may lead to less blood
filled knees, and thus to a greater improvement in postoperative pain scores when compared
to the control group. The two arms of the study will include:
1. experimental group in which Vitagel® is used unilateral TKA
2. control group representing our current standard of care (no Vitagel®)
A comparison of the functional and clinical results between these two groups will be
conducted using several outcome measures including the KOOS, SF-12 version2 and pain scores
through the previously IRB approved OrthoMidas registry. The primary variable of interest is
blood loss, based on hemoglobin drop during the postoperative hospital stay. Of secondary
interest will be; 1) pain levels in the PACU, 2) pain scores for all postoperative days, 3)
average pain for the entire hospital stay, 4) length of stay, 5) patient satisfaction at
discharge, 4 weeks postoperative, and 12 weeks postoperative, and 6) functional scores at 4
and 12 weeks postoperative.
This is a prospective, single-center, randomized, double-blinded, clinical trial involving
three orthopaedic surgeons who perform total knee replacement. The proposed study is optimal
for obtaining clinical and functional comparisons between TKA surgical procedures utilizing
conventional practices (control) and TKA utilizing Vitagel®, a surgical hemostat used to
control bleeding and facilitate healing. The study will include patients that are receiving
a unilateral primary TKA.
Fifty cases will be assigned to each arm of the study (total 100 cases). This sample size
was estimated using an alpha of 0.05 (conventional for all studies) and a beta of 0.80
(recommended for superiority studies). The standard deviation is based on a study conducted
by the PI at the Cleveland Clinic in an IRB approved retrospective project in 2007, and will
provide in excess of 80 percent statistical power in detecting less than a 100 ml difference
in blood loss between the two groups.
The study will be conducted at the Cleveland Clinic (Cleveland, OH). The patients will not
be informed of their treatment assignment, and the research investigator making observations
and recording the data postoperatively will also be blinded to their treatment assignment.
The placement of patients into treatment arms will be based on random drawing of sealed
envelopes. An assessment of blinding will be conducted at the conclusion of the study by
asking patients what treatment they think that they received.
Data will be collected at four timepoints, including preoperatively, during the hospital
stay, 4 weeks postoperatively, and 12 weeks postoperatively. Preoperative data collected
will include baseline SF-12, KOOS, hemoglobin and hematocrit levels, and pain scores. Data
collected in the hospital will include hemoglobin and hematocrit levels, pain scores,
narcotics usage, length of stay, and patient satisfaction at discharge. The SF-12, KOOS,
pain scores, and patient satisfaction will be collected utilizing the 4 week (±2 weeks)
standard of care postoperative visit. Patients are not always seen at the 12 week (±4 weeks)
postoperative timepoint as standard of care. To collect these data, patients will be mailed
the SF-12, KOOS, pain scores, patient satisfaction, and blinding assessment questionnaires.
Patients not responding to the initial mailer will be contacted by phone and sent a second
packet of questionnaires.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04228458 -
ThermRheum Version 1
|
N/A | |
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Completed |
NCT00069342 -
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases
|
||
Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
Recruiting |
NCT02498808 -
Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?
|
N/A | |
Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
Enrolling by invitation |
NCT02487888 -
A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care
|
N/A | |
Withdrawn |
NCT02136251 -
Total Shoulder Replacement Outcomes With Autologous Bone Graft as Fixator for Glenoid Anchor Peg.
|
||
Completed |
NCT02143206 -
Modifying Exercise for the COPD Patient
|
||
Completed |
NCT01407874 -
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
|
Phase 2 | |
Completed |
NCT01285843 -
Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component
|
N/A | |
Completed |
NCT00987870 -
Safety and Efficacy of BFH772 in Psoriasis Patients
|
Phase 1/Phase 2 | |
Completed |
NCT01172327 -
Self-Directed Exercise Program for Adults With Arthritis
|
N/A | |
Completed |
NCT00750984 -
A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing
|
N/A | |
Completed |
NCT01184924 -
Evaluation of the Arthritis Foundation Tai Chi Program
|
N/A | |
Active, not recruiting |
NCT00611585 -
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
|
N/A | |
Completed |
NCT00379184 -
Sensitization in Osteoarthritic Knees
|
N/A | |
Completed |
NCT00175448 -
Comparison of Physiotherapy Versus Home Exercise Following Hip Replacement Surgery
|
N/A | |
Completed |
NCT00403676 -
Nursing Consultation in Out-patient Clinics for Patients With Inflammatory Rheumatic Disease
|
N/A |